Is Mounjaro an Injection? Understanding the Basics and Benefits of This Innovative Treatment

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Mounjaro is administered as a once-weekly subcutaneous injection that delivers tirzepatide, a medication that activates two separate hormone pathways in the body. Unlike older single-pathway GLP-1 drugs, tirzepatide targets both glucagon-like peptide-1 and glucose-dependent insulinotropic peptide receptors, making it a dual-mechanism approach to weight management. Understanding how this injectable therapy works can help you decide if it aligns with your health goals.

How Tirzepatide Injection Works in the Body

Tirzepatide functions by mimicking two natural hormones that regulate blood sugar and appetite signaling. When you inject tirzepatide once per week, it binds to GLP-1 receptors in your brain, slowing gastric emptying so you feel fuller longer. It simultaneously activates GIP receptors, which enhance the body's natural insulin response and promote metabolic stability, addressing both hunger and energy balance through a single compound.

Clinical trials demonstrated that participants receiving tirzepatide experienced sustained weight loss over 72 weeks, with some achieving double-digit percentage reductions in body weight. The dual-receptor mechanism allows tirzepatide to work on multiple metabolic pathways simultaneously, potentially offering greater effectiveness than medications targeting only one receptor. This science-backed approach is why tirzepatide has gained recognition as a breakthrough option for weight management.

Injectable vs. Oral Tirzepatide: Which Form is Right for You

Tirzepatide exists in two delivery forms: injectable and oral. The injectable version requires a once-weekly subcutaneous injection, similar to administering insulin, while oral tirzepatide involves daily tablets. Most people find injections convenient because they require only one dose per week, reducing the need for daily medication management and improving adherence to treatment plans.

Absorption rates differ between the two forms, which can influence how quickly you experience effects and how your body responds. Injectable tirzepatide delivers medication directly into subcutaneous tissue, allowing for consistent weekly dosing with predictable blood levels. PlexusDx offers both compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan and oral tirzepatide, allowing you to select the delivery method that best fits your lifestyle and preferences.

Why Choose Compounded Tirzepatide Over Brand-Name Mounjaro

Compounded tirzepatide from licensed 503A pharmacies provides pharmaceutical-grade quality at a significantly lower cost than brand-name Mounjaro. PlexusDx sources compounded tirzepatide injections from verified 503A compounding facilities, ensuring stringent quality standards and regulatory compliance without the premium pricing of proprietary formulations. Since your dose may need to go up during treatment, you'll appreciate pricing that stays flat regardless of dose adjustments—your tirzepatide injection remains $289 per month whether you're starting at 2.5 mg or advancing to higher therapeutic doses.

Many patients find that switching to compounded options removes financial barriers to accessing this proven medication. Insurance is not required, and PlexusDx accepts HSA and FSA funds, making treatment accessible to a broader range of people. The compounded alternative delivers the same active pharmaceutical ingredient as brand-name versions but eliminates marketing and distribution markups that inflate patient costs.

Genetic Personalization: Optimizing Your Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predispositions allows PlexusDx practitioners to personalize your treatment plan before investing time and money into a medication that may not align with your biology. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, providing data-driven confidence in your tirzepatide selection. This precision-medicine approach transforms weight loss from a one-size-fits-all experiment into a targeted, evidence-based strategy tailored to your unique peptide pathways.

Getting Started with PlexusDx Tirzepatide Injections

Starting tirzepatide injections through PlexusDx begins with a straightforward online consultation and health assessment. PlexusDx serves all 50 states without requiring insurance, eliminating geographic barriers and insurance approval delays that often prevent timely access to this therapy. Once approved, your compounded tirzepatide injections ship directly to your home, arriving with clear instructions for self-administration.

PlexusDx tirzepatide injection pricing is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flat across all dose tiers, meaning you never pay more as your therapeutic dose increases. The three commitment tiers provide flexibility in how you structure your treatment, and HSA or FSA funds can be applied toward your monthly cost. If you want genetic insights to optimize your response, add the Precision Peptide Genetic Test in your second month for comprehensive personalized care.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro definitely an injection, or can you get it as a pill?

Mounjaro is exclusively an injectable medication administered once weekly. However, tirzepatide—the active ingredient in Mounjaro—is now available in oral form through compounding pharmacies like those supplying PlexusDx. PlexusDx offers both compounded tirzepatide injections ($289/mo) and oral tirzepatide ($349/mo), giving you flexibility to choose your preferred delivery method.

How much weight loss can I expect with tirzepatide injections?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Why is PlexusDx compounded tirzepatide cheaper than Mounjaro?

PlexusDx sources tirzepatide from licensed 503A compounding pharmacies, which manufacture the medication at lower cost than brand-name Mounjaro while maintaining pharmaceutical-grade quality. Additionally, PlexusDx eliminates insurance middlemen and passes savings directly to patients—compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with flat pricing across all dose levels. No membership fees or insurance requirements mean you pay only for the medication you receive.

Are there side effects specific to tirzepatide injections?

Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and temporary as your body adjusts. Because tirzepatide activates two receptor pathways rather than one, some patients experience different side effect profiles compared to single-pathway GLP-1 medications. Discuss any concerns with your PlexusDx practitioner, who can adjust your dose or recommend supportive strategies.

How does the Precision Peptide Genetic Test improve my tirzepatide outcomes?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Mounjaro
• Mounjaro Injection Price
• Mounjaro Injection Sites
• Mounjaro Injection Site

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.